Can procalcitonin testing reduce antibiotic prescribing for respiratory infections? [1]

Age and Ageing

Volumn 35, Issue 6, 2006, Pages 625-626

  Bignardi, Giuseppe E ^a   Dhar, R ^b   Heycock, R ^c   Bansal, S ^a   Majmudar, N ^a  

^a SUNDERLAND ROYAL HOSPITAL   (United Kingdom)

^b FREEMAN HOSPITAL   (United Kingdom)

^c University Hospital of Hartlepool   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; C REACTIVE PROTEIN; DOXYCYCLINE; PROCALCITONIN;

AGED; ANTIBIOTIC THERAPY; BACTERIAL INFECTION; CLOSTRIDIUM DIFFICILE; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COST CONTROL; DIAGNOSTIC TEST; DRUG USE; DRUG WITHDRAWAL; HEALTH CARE COST; HUMAN; LETTER; LOWER RESPIRATORY TRACT INFECTION; MAJOR CLINICAL STUDY; MEDICAL AUDIT; PRESCRIPTION; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; UNSPECIFIED SIDE EFFECT;

AGED; ANTI-BACTERIAL AGENTS; BIOLOGICAL MARKERS; CALCITONIN; DRUG UTILIZATION; HUMANS; PNEUMONIA, BACTERIAL; PROTEIN PRECURSORS;

EID: 33750332696     PISSN: 00020729     EISSN: 14682834     Source Type: Journal    
DOI: 10.1093/ageing/afl054     Document Type: Letter

References (9)

1. Christ-Crain M, Jaccard-Stolz D, Bingisser R et al. Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: Cluster-randomised, single-blinded intervention trial. Lancet 2004; 363: 600-7.
2. Bignardi GE. Risk factors for Clostridium difficile infection. J Hosp Infect 1998; 40: 1-15.
3. Coello R, Glynn JR, Gaspar C, Picazo JJ, Fereres J. Risk factors for developing clinical infection with methicillin resistant Staphylococcus aureus (MRSA) amongst hospital patients initially only colonised with MRSA. J Hosp Infect 1997; 37: 39-46.
4. Marshall C, Wolfe R, Kossmann T, Wesselingh S, Harrington G, Spelman D. Risk factors for acquisition of methicillin-resistant Staphylococcus aureus (MRSA) by trauma patients in the intensive care unit. J Hosp Infect 2004; 57: 245-52.
5. Stone SP, Beric V, Quick A, Balestrini AA, Kibbler CC. The effect of an enhanced infection-control policy on the incidence of Clostridium difficile and methicillin-resistant Staphylococcus aureus colonization in acute elderly medical patients. Age Ageing 1998; 27: 561-8.
6. Pépin J, Valiquette L, Alary ME et al. Clostridium difficile-associated diarrhoea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity. CMAJ 2004; 171: 466-72.
7. Health Protection Agency. Outbreak of Clostridium difficile infection in a hospital in south east England. CDR Weekly 2005; 15: 2-3.
8. Simon L, Gauvin F, Amre DK, Saint-Louis P, Lacroix J. Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: A systematic review and meta-analysis. Clin Infect Dis 2004; 39: 206-17.
9. Wilcox MH, Cunniffe JG, Trundle C, Redpath C. Financial burden of hospital-acquired Clostridium difficile infection. J Hosp Infect 1996; 34: 23-30.